Syros Pharmaceuticals — Company Overview, News & Financial Data

Syros Pharmaceuticals (NASDAQ:SYRS) is a biopharmaceutical company focused on the development of treatments for cancer and diseases caused by gene dysregulation. The company leverages its proprietary gene control platform to systematically identify and target the regulatory genes that are the root cause of these serious illnesses. With a commitment to transforming the lives of patients, Syros is advancing a diverse pipeline of small molecules that are designed to control the expression of genes implicated in disease onset and progression. Their objective is to achieve a new wave of medicines that precisely control the expression of genes critical for the health of individuals with conditions that presently have limited treatment options.